Jeff Schaffnit Shares Sanofi’s Patient Advocacy Voices Series with Caroline Kruse
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared on LinkedIn:
”Many people living with immune thrombocytopenia (ITP) face a critical hurdle: getting a proper diagnosis.
Caroline Kruse, President and CEO of the Platelet Disorder Support Association – PDSA, and other experts know this challenge well.
Despite the organization’s over 25 years of educating, supporting and advocating for the ITP community, diagnosis remains one of the most critical unmet needs for people living with ITP and other rare blood disorders.
My colleague Eric Racine, PharmD, MBA had the opportunity to speak with Caroline as part of Sanofi’s Patient Advocacy Voices series.
We stand proudly with PDSA and the ITP community in our commitment to raising awareness and supporting people living with ITP.
Watch the full conversation here.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?